Trial Profile

SIMPLE Study: A Prospective and Randomized Trial of a Simplified Immunosuppressive Protocol Utilizing Low Dose EnvarsusXR

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 13 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tacrolimus (Primary) ; Antithymocyte globulin; Azathioprine; Basiliximab; Methylprednisolone; Mycophenolate mofetil; Mycophenolic acid; Prednisone; Tacrolimus
Indications Renal transplant rejection
Focus Therapeutic Use
Acronyms SIMPLE

Most Recent Events

10 Nov 2025 Status changed from recruiting to discontinued.
07 Dec 2023 Planned primary completion date changed from 1 Feb 2023 to 1 Feb 2025.
04 Dec 2023 Planned End Date changed from 1 Feb 2023 to 1 Feb 2025.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com